Thanks for the clarification. To date, I don’t think EXEL has presented data that could realistically support accelerated approval in CRPC. Does anyone here disagree?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.